Table 3

Infections recorded for Indigenous and non-Indigenous adults during the 5 years prior to the final BSI presentation*

Indigenous n=431 (%)Non-Indigenous (n=52)p Value
Any296 (68.7)18 (34.6)<0.001
BSI105 (24.4)4 (7.7)0.007
Respiratory tract179 (41.5)3 (5.8)<0.001
 Pneumonia164 (38.1)4 (7.7)<0.001
 >3 Episodes32 (7.4)0 (0.0)0.04
 Exacerbation BE13 (6.0)0 (0.0)0.20
Skin/soft tissue infections154 (35.7)7 (13.5)0.001
 Abscess88 (20.5)0 (0.0)<0.001
 Cellulitis47 (10.9)7 (13.7)0.55
 Wound infection42 (9.7)0 (0.0)0.02
Pyelonephritis77 (17.9)4 (7.7)0.06
Bone/joint11 (2.6)0 (0.0)0.24
Enteritis21 (4.9)1 (1.9)0.33
Scabies14 (3.3)0 (0.0)0.19
Other6 (1.4)0 (0.0)0.39

  • *Excluding haemodialysis patients (n=83 indigenous, 3 non-indigenous), patients with bronchiectasis (n=27 Indigenous, 0 non-indigenous) and those residing outside the Alice Springs urban and rural districts for whom data were not available (Indigenous, 18; non-Indigenous, 0).

  • BSI, bloodstream infections; BE, bronchiectasis.